Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-13 @ 7:48 AM
Study NCT ID:
NCT00947167
Status:
TERMINATED
Last Update Posted:
2017-03-03
First Post:
2009-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
Sponsor:
Pamela L. Kunz
Organization: